Q1 2027 Rossari Biotech Ltd Earnings Call Transcript
Key Points
- Rossari Biotech Ltd (BOM:543213) achieved its highest ever quarterly revenue and EBITDA, with a 28% year-on-year growth in consolidated revenue.
- The company has seen healthy momentum in its domestic business and continued expansion of its international presence.
- The new R&D center is ramping up, enhancing collaboration, accelerating new product development, and supporting faster commercialization of technologies.
- Rossari Biotech Ltd (BOM:543213) has strengthened its textile specialty chemicals portfolio with the launch of a dedicated fiber chemicals division.
- The company is well-positioned in the agrochemical sector, supported by increasing demand for advanced formulations and sustainable agricultural solutions.
- Margins remain below their normalized potential, with the EBITDA margin at 11.6% compared to 12.5% in the corresponding quarter last year.
- The institutional and consumer businesses have weighed on overall profitability, with efforts underway to optimize costs and improve operational efficiency.
- The company faces challenges in passing on raw material price increases due to volatility and geopolitical uncertainties.
- The Thailand plant, while operational, is still ramping up and currently contributes a small portion to overall revenue.
- The Saudi Arabia initiative is still in the exploratory phase, with no finalized plans, which may delay potential benefits.
Ladies and gentlemen, good day, and welcome to the Rosari Biotech Limited's earnings conference call.
(Operator Instructions)
Please note that this conference is being recorded.
I now hand the conference over to Mr. Mitesh Jain from CDR India.
Thank you, and over to you, Mr. Jain.
Thank you, Swapnali. Good evening, everyone, and thank you for joining us on Rukhzari Biotech Limited's Q1 FY27 Earnings Conference Hall. We have with us Mr. Edward Manages, Promoter and Executive Chairman, Mr. Sunil Chari, Promoter and Managing Director, and Mr. Ketan Sablo, Group's Chief Financial Officer of the company.
We will begin the call with opening remarks from the management, following which we will have the forum open for a question-and-answer session.
Before we start, I would like to point out that some statements made in today's call may be forward-looking in nature, and a disclaimer to this effect has been included in the earnings presentation shared with you all of the year.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
